Trending Posts
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology, and Immunology Treatments…
XtalPi and Eli Lilly Partner in $250M AI-Driven…
Cambridge, MA – June 1 2023 XtalPi Inc., a pioneering AI-powered pharmaceutical technology company, has announced a strategic…
XtalPi and Janssen Partner to Accelerate AI-Driven Small…
Shenzhen, China – Oct 27 2022 XtalPi Inc., a leading AI-powered pharmaceutical technology company, announced a strategic research…
GSK Expands AI Capabilities with $70 Million Tempus…
London, UK – October 18, 2022 GSK has entered into a $70 million agreement with Tempus, a leader…
Eli Lilly and Genesis AI Announce $670M AI-Driven…
BURLINGAME, California – May 3, 2022 Harnessing AI to Unlock Breakthrough Therapies Eli Lilly and Company and Genesis…
Genesis AI and Genentech (Roche) Form Multi-Target AI…
BURLINGAME, California – Oct 19, 2020 Genesis Therapeutics, a pioneer in AI-driven drug discovery, has announced a multi-target…
Trending Posts
Latest Stories
How Will Ambience Healthcare’s $243M Series C Propel AI-Driven Clinical Documentation to Transform Healthcare’s Future?
Key Highlights Transforming Clinical Documentation and Workflow with Ambient AIAmbience’s platform listens passively to clinical…
What Impact Will the Trump Administration’s Private Health Data Initiative Have on Patient Privacy and Healthcare Innovation?
Key Highlights Transforming Access to Health Data Through Private Sector-Led InnovationThe Trump Administration aims to…
Can Viridian Therapeutics’ $70M Collaboration with Kissei Pharmaceutical Accelerate Best-in-Class Treatments for Thyroid Eye Disease in Japan?
Key Highlights Strategic Collaboration Combines Strengths to Advance TED Treatment in JapanViridian Therapeutics partners exclusively…
Can Merck’s $3 Billion Restructuring Drive Sustainable Growth Amidst Patent Challenges?
About MerckMerck & Co., Inc. (MSD outside US & Canada) is a global biopharmaceutical company…









